{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2023"],"condition":["Polyp of colon","Malignant neoplasm of colon, unspecified"],"disease":["Polyp Of Colon","Malignant Neoplasm Of Colon, Unspecified"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/76824"],"location":["India"],"study_start_month":["5"],"repository":["ECRIN MDR"],"study_status":["Not yet recruiting"],"additional_accession":[]},"is_claimable":false,"name":"To study gene mutations in colorectal cancer enzymatically.","description":"Primary outcome(s): The primary outcome of the study will be assessment of immunopositivity of BRAF in precancerous and cancerous lesions of colorectum.Timepoint: 2 years","dates":{"creation":"2023-05-15"},"accession":"76824","cross_references":{"Clinical Trials Registry - India":["CTRI-2023-05-053332"]}}